Pharmaceutical products

Tender description

Supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG). This framework has been awarded in four (4) categories, each of which is identified as a ‘Lot’ as detailed in the contract notice. The Lots are as follows: Lot 1 — Human Normal Intravenous Immunoglobulin 5 % Lot 2 — Human Normal Intravenous Immunoglobulin 10 % Lot 3 — Human Normal Intravenous Immunoglobulin for Subcutaneous Use Lot 4 — Subcutaneous Immunoglobulin with Hyaluronidase All deliveries under the framework agreement will be to one central location, namely ‘The Scottish National Blood Transfusion Service’ (SNBTS), Edinburgh. Supply of Human Normal Intravenous Immunoglobulin for subcutaneous use across various vial sizes including current Primary Immune Deficiencies (PID) usage. This lot has been awarded as a Ranked Multi Supplier Framework. Supply of Human Normal Intravenous Immunoglobulin 5 %, across various vial sizes including current Primary Immune Deficiencies (PID) usage. This lot has been awarded as a Ranked Multi Supplier Framework. Supply of Human Normal Intravenous Immunoglobulin 10 %, across various vial sizes including current Primary Immune Deficiencies (PID) usage. This lot has been awarded as a Ranked Multi Supplier Framework. Supply of Subcutaneous Immunoglobulin with Hyaluronidase. The Authority has awarded all presentations within this Lot to a single supplier.